Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member C4 (DNAJC4) is a protein coding gene and a member of the Hsp40/DnaJ co-chaperone family, characterized by a conserved J-domain that regulates the activity of Hsp70 chaperones. DNAJC4 participates in protein homeostasis, particularly through assisting the folding of newly synthesized and misfolded proteins and mediating the response to cellular stress involving unfolded proteins. It is predicted to localize to cellular membranes, based on current protein atlas data. While DNAJC4 is associated with protein folding diseases and multiple endocrine neoplasia by genetic studies, there are currently no known drugs directly targeting DNAJC4, nor is it considered a typical therapeutic target at this time[1][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member C4 (DNAJC4).